Considerations for the genotoxicity assessment of middle size peptide drugs containing non-canonical amino acid residues.

MLA

Mishima, Masayuki, and Kei-ichi Sugiyama. “Considerations for the Genotoxicity Assessment of Middle Size Peptide Drugs Containing Non-Canonical Amino Acid Residues.” Genes & Environment, vol. 45, no. 1, Dec. 2023, pp. 1–6. EBSCOhost, https://doi.org/10.1186/s41021-023-00294-1.

APA

Mishima, M., & Sugiyama, K. (2023). Considerations for the genotoxicity assessment of middle size peptide drugs containing non-canonical amino acid residues. Genes & Environment, 45(1), 1–6. https://doi.org/10.1186/s41021-023-00294-1

Chicago

Mishima, Masayuki, and Kei-ichi Sugiyama. 2023. “Considerations for the Genotoxicity Assessment of Middle Size Peptide Drugs Containing Non-Canonical Amino Acid Residues.” Genes & Environment 45 (1): 1–6. doi:10.1186/s41021-023-00294-1.